BamSEC and AlphaSense Join Forces
Learn More

Icosavax Inc

Formerly NASDAQ: ICVX

Material Contracts Filter

EX-10.4
from 10-Q 13 pages June 7, 2023 Re: Employment Letter Agreement 4. Base Salary and Employee Benefits
12/34/56
EX-10.3
from 10-Q 8 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Public Health Service Amendment
12/34/56
EX-10.2
from 10-Q 35 pages Amended and Restated Exclusive License Agreement [***]
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 13 pages Amendment No. 3 to Exclusive License Agreement [***]
12/34/56
EX-10.1
from 10-Q 5 pages This Annual Bonus Plan (The “Plan”) Is Adopted Under the Icosavax, Inc. 2021 Incentive Award Plan (The “2021 Plan”) and Is Intended to Provide an Incentive for Eligible Employees of Icosavax, Inc. (The “Company”) to Perform to the Best of Their Abilities, to Further the Growth, Development and Financial Success of the Company, and to Enable the Company to Attract and Retain Highly Qualified Employees. for Purposes of the Plan, the “Plan Year” Shall Mean Each Calendar Year. 2. Administration
12/34/56
EX-10.19
from 10-K 31 pages Non-Exclusive License Agreement Between Icosavax, Inc. and University of Washington for Computationally Designed Nanoparticles and Flu Vaccines Based Upon Such Designs Uw Comotion Agreement Ref. [***]
12/34/56
EX-10.18
from 10-K 47 pages Boren Labs 1930 Boren Avenue Seattle, Washington Lease Agreement Between Boren Lofts Owner (De) LLC, a Delaware Limited Liability Company, as Landlord and Icosavax, Inc., a Delaware Corporation, as Tenant
12/34/56
EX-10.10
from 10-Q 13 pages August 9, 2021 via Email Elizabeth Bekiroglu Re: Employment Letter Agreement 1. Commencement of Employment. Employee’s Employment With the Company Will Commence on September 7, 2021 (The “Effective Date”). 2
12/34/56
EX-10.17
from S-1/A 10 pages July 22, 2021 Thomas J. Russo C/O Icosavax, Inc. Re: Employment Letter Agreement Dear Thomas
12/34/56
EX-10.16
from S-1/A 10 pages 1. Position. Employee Will Continue to Serve in the Position Senior Vice President, Technical Operations. Employee Will Continue to Report to the Company’s Chief Executive Officer, and Shall Be Responsible for the Duties Customarily Associated With This Position and Such Other Duties Assigned by the Company. Employee Will Work at the Company’s Facility Located at Seattle, Washington. of Course, the Company May Change Employee’s Position, Duties, and Work Location From Time to Time in Its Discretion. Employee Will Be Employed on a Full-Time Basis. This Is an Exempt Position. 2. Base Salary and Employee Benefits. (A) Salary. Employee’s Base Salary Will Be $360,000.00 Per Year (The “Base Salary”), Less Payroll Deductions and Withholdings, Paid on the Company’s Normal Payroll Schedule
12/34/56
EX-10.15
from S-1/A 10 pages July 22, 2021 Cassia Cearley C/O Icosavax, Inc. Re: Employment Letter Agreement Dear Cassia
12/34/56
EX-10.14
from S-1/A 10 pages July 22, 2021 Niranjan Kanesa-Thasan C/O Icosavax, Inc. Re: Employment Letter Agreement Dear Niranjan
12/34/56
EX-10.13
from S-1/A 10 pages July 22, 2021 Douglas Holtzman C/O Icosavax, Inc. Re: Employment Letter Agreement Dear Douglas
12/34/56
EX-10.12
from S-1/A 11 pages July 22, 2021 Adam Simpson C/O Icosavax, Inc. Re: Employment Letter Agreement Dear Adam
12/34/56
EX-10.4
from S-1/A 3 pages Icosavax, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.3
from S-1/A 15 pages Icosavax, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 30 pages Icosavax, Inc. 2021 Incentive Award Plan
12/34/56
EX-10.24
from S-1 25 pages Background
12/34/56
EX-10.23
from S-1 11 pages Global Access and Price Commitment Agreement Investment Id [***]
12/34/56